Mathoulin-Pelissier S - Search Results

1

Quality of randomized controlled trials reporting in the treatment of sarcomas.

Toulmonde M, Bellera C, Mathoulin-Pelissier S, Debled M, Bui B, Italiano A. Toulmonde M, et al. J Clin Oncol. 2011 Mar 20;29(9):1204-9. doi: 10.1200/JCO.2010.30.9369. Epub 2011 Feb 14. J Clin Oncol. 2011. PMID: 21321290

2

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial.

Ravaud A, Trufflandier N, Ferrière JM, Debled M, Palussière J, Cany L, Gaston R, Mathoulin-Pélissier S, Bui BN. Ravaud A, et al. Br J Cancer. 2003 Dec 15;89(12):2213-8. doi: 10.1038/sj.bjc.6601419. Br J Cancer. 2003. PMID: 14676797 Free PMC article. Clinical Trial.

3

Time for reappraisal of progesterone-receptor testing in breast cancer management.

MacGrogan G, de Mascarel I, Sierankowski G, Mauriac L, Debled M, Durand M, De Lara CT, Avril A, Picot V, Mathoulin-Pélissier S. MacGrogan G, et al. J Clin Oncol. 2005 Apr 20;23(12):2870-1; author reply 2871. doi: 10.1200/JCO.2005.05.241. J Clin Oncol. 2005. PMID: 15838009 No abstract available.

4

Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.

Debled M, MacGrogan G, Brouste V, Mathoulin-Pelissier S, Durand M, Mauriac L. Debled M, et al. Cancer. 2007 Jun 1;109(11):2197-204. doi: 10.1002/cncr.22667. Cancer. 2007. PMID: 17450590 Free article.

5

Survival end point reporting in randomized cancer clinical trials: a review of major journals.

Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, Kramar A. Mathoulin-Pelissier S, et al. J Clin Oncol. 2008 Aug 1;26(22):3721-6. doi: 10.1200/JCO.2007.14.1192. J Clin Oncol. 2008. PMID: 18669458 Review.

6

Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?

de Mascarel I, MacGrogan G, Vincent-Salomon A, Mathoulin-Pélissier S, Brouste V, Sigal-Zafrani B, Debled M, Mauriac L, de Lara CT. de Mascarel I, et al. J Clin Oncol. 2008 Sep 20;26(27):4514-5; author reply 4515. doi: 10.1200/JCO.2008.18.6205. J Clin Oncol. 2008. PMID: 18802166 No abstract available.

7

D2-40 in breast cancer: should we detect more vascular emboli?

de Mascarel I, MacGrogan G, Debled M, Sierankowski G, Brouste V, Mathoulin-Pélissier S, Mauriac L. de Mascarel I, et al. Mod Pathol. 2009 Feb;22(2):216-22. doi: 10.1038/modpathol.2008.151. Epub 2008 Sep 26. Mod Pathol. 2009. PMID: 18820667 Free article.

8

Management of unfit patients with unfavourable non-Hodgkin's lymphomas.

Soubeyran P, Mertens C, Bellera C, Mathoulin-Pélissier S, Rainfray M. Soubeyran P, et al. Cancer Treat Rev. 2009 Oct;35(6):528-32. doi: 10.1016/j.ctrv.2009.04.001. Epub 2009 Sep 16. Cancer Treat Rev. 2009. PMID: 19762154

9

Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.

Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V, Mathoulin-Pélissier S. Bellera CA, et al. BMC Med Res Methodol. 2010 Mar 16;10:20. doi: 10.1186/1471-2288-10-20. BMC Med Res Methodol. 2010. PMID: 20233435 Free PMC article.

10

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database.

Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, Trassard M, Michels JJ, Blay JY, Coindre JM, Bui B. Italiano A, et al. Ann Oncol. 2010 Dec;21(12):2436-2441. doi: 10.1093/annonc/mdq238. Epub 2010 May 3. Ann Oncol. 2010. PMID: 20439343 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters